Section 49
Chapter 48,919

Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease

Miller, W.M.; Nori Janosz, K.E.; Yanez, J.; McCullough, P.A.

Expert Review of Cardiovascular Therapy 3(4): 743-759


ISSN/ISBN: 1744-8344
PMID: 16076283
DOI: 10.1586/14779072.3.4.743
Accession: 048918056

Obesity is currently an epidemic, and the prevalence of cardiovascular risk factors is increasing dramatically as a result. Visceral adiposity is correlated with a proinflammatory and prothrombotic state that is believed to promote atherosclerosis and acute coronary syndromes. This article will review clinical trials on the effects of weight loss and pharmacotherapy on obesity associated inflammatory and thrombotic markers linked with cardiovascular disease.

PDF emailed within 0-6 h: $19.90